BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Woods N, MacLoughlin R. Defining a Regulatory Strategy for ATMP/Aerosol Delivery Device Combinations in the Treatment of Respiratory Disease. Pharmaceutics 2020;12:E922. [PMID: 32993197 DOI: 10.3390/pharmaceutics12100922] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Shin H, Kim E. Analysis of GMP for marketing authorization of ATMPs: comparison in the US, the EU, Japan and South Korea. Regen Med 2022. [PMID: 35232285 DOI: 10.2217/rme-2021-0153] [Reference Citation Analysis]
2 Yoshioka K, Kurashina Y, Ogawa A, Asakura T. Effect of the area of a lithium niobate transducer on the efficiency of ultrasonic atomization driven by resonance vibration. Ultrasonics Sonochemistry 2022;86:106019. [DOI: 10.1016/j.ultsonch.2022.106019] [Reference Citation Analysis]
3 Brennan LC, O'Sullivan A, MacLoughlin R. Cellular Therapy for the Treatment of Paediatric Respiratory Disease. Int J Mol Sci 2021;22:8906. [PMID: 34445609 DOI: 10.3390/ijms22168906] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Fröhlich E. Therapeutic Potential of Mesenchymal Stem Cells and Their Products in Lung Diseases-Intravenous Administration versus Inhalation. Pharmaceutics 2021;13:232. [PMID: 33562240 DOI: 10.3390/pharmaceutics13020232] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]